Researcher.Life Logo

BMC Biotechnology : Impact Factor & More

eISSN: 1472-6750pISSN: 1472-6750
JournalOpen Access

Key Metrics

CiteScore
5
Impact Factor
< 5
SJR
Q2Biotechnology
SNIP
0.89
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on BMC Biotechnology

BMC Biotechnology Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • Inspec Inspec
  • SJR SJR
Overview
Publisher BMC
Language English
Frequency Continuous publication
Article Processing ChargesEUR 2290 | USD 2690 | GBP 1990
Publication Time20
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2000
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 20
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC0
OA statementVisit website
View less

Planning to publish in BMC Biotechnology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in BMC Biotechnology

Editorial Expression of Concern: Hindering the biofilm of microbial pathogens and cancer cell lines development using silver nanoparticles synthesized by epidermal mucus proteins from Clarias gariepinus.
  • 30 Jun 2026
  • BMC biotechnology
Computer-guided enzyme engineering of PET hydrolase mutants towards improved PET affinity.
  • 29 Jun 2026
  • BMC biotechnology
Integrated structure-based and systems-level identification of PDE9A inhibitors for heart failure with preserved ejection fraction.
  • 24 Jun 2026
  • BMC biotechnology
Production and partial characterization of fructose-rich exopolysaccharide from a newly isolated halophilic strain Vreelandella sp. DT-Z4.
  • 24 Jun 2026
  • BMC biotechnology
Multi-omic characterization of a soil microbial consortium reveals critical role of succinate and glutamate metabolism during calcium carbonate precipitation.
  • 23 Jun 2026
  • BMC biotechnology
Integrative analysis identifies the intratumoral Fusobacterium nucleatum as a driver of cervical cancer malignancy.
  • 23 Jun 2026
  • BMC biotechnology
Editorial Expression of Concern: Hindering the biofilm of microbial pathogens and cancer cell lines development using silver nanoparticles synthesized by epidermal mucus proteins from Clarias gariepinus.
  • 30 Jun 2026
  • BMC biotechnology
Computer-guided enzyme engineering of PET hydrolase mutants towards improved PET affinity.
  • 29 Jun 2026
  • BMC biotechnology
Integrated structure-based and systems-level identification of PDE9A inhibitors for heart failure with preserved ejection fraction.
  • 24 Jun 2026
  • BMC biotechnology
Production and partial characterization of fructose-rich exopolysaccharide from a newly isolated halophilic strain Vreelandella sp. DT-Z4.
  • 24 Jun 2026
  • BMC biotechnology
Multi-omic characterization of a soil microbial consortium reveals critical role of succinate and glutamate metabolism during calcium carbonate precipitation.
  • 23 Jun 2026
  • BMC biotechnology
Integrative analysis identifies the intratumoral Fusobacterium nucleatum as a driver of cervical cancer malignancy.
  • 23 Jun 2026
  • BMC biotechnology

FAQs on BMC Biotechnology